Supernus Pharmaceuticals Inc (NASDAQ:SUPN) is one of the top percentage gainers in NASDAQ. The stock soared 21.61% to $13.0. Recently, the Company announced that it received a tentative approval letter from the Food & Drug Administration for Trokendi XR. This is a once-daily extended release formulation of topiramate. The letter states that the FDA completed its review of the Trokendi XR NDA and that no additional clinical trials are required.
Should Investors Buy SUPN after Today’s Rally? Get Free Trend Analysis
Galena Biopharma Inc (NASDAQ:GALE) climbed up 18.72% to $2.04. The Company announced the issuance of a key patent, originally allowed in March 2012 from the U.S. Patent and Trademark Office covering the use of NeuVax. NeuVax is a vaccine for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC levels of 1+ or 2+ and a FISH rating of less than 2.0.
Should Investors Buy GALE after Today’s Rally? Get Free Trend Analysis
AAR Corp (NYSE:AIR) soared 13.34% to $14.36. The Company reported fourth quarter net income of $12.9 million or $0.32 per share compared to $21.4 million or $0.52 per share in the prior quarter last year. Sales for the quarter were $563.3 million compared to $487.8 million in the previous year quarter. However, analysts expected the Company to earn $0.46 per share for the quarter.
The Board of Directors declared a quarterly cash dividend of $0.075 per share. The dividend will be paid on August 9, 2012
How Should Investors Trade AIR, Get Free Trend Analysis
Amphenol Corporation (NYSE:APH) increased 14.15% to $58.63 on a traded volume of 2.27 million shares after the Company reported second quarter results. Diluted earnings per share were $.86 compared to $.85 per share in the prior year period. Sales were $1.061 billion compared to $1.018 billion in the previous year period.
. Should Investors Buy APH after Today’s Rally? Get Free Trend Analysis
Whiting USA Trust I (NYSE:WHX) plunged 24.92% to $12.26 on a traded volume of 1.15 million shares. The 52-week range of the stock $11.60 and $19.15.The Company has Price/Sales ratio of 5.31 and Price/Book ratio of 5.35. The 50-Day Moving Average and 200-Day Moving Average prices is $17.48 and $17.50 respectively.